Unichem Laboratories Limited (NSE:UNICHEMLAB)
625.55
-22.00 (-3.40%)
Jun 12, 2025, 3:29 PM IST
Unichem Laboratories Revenue
In the fiscal year ending March 31, 2025, Unichem Laboratories had annual revenue of 21.11B INR with 23.82% growth. Unichem Laboratories had revenue of 5.87B in the quarter ending March 31, 2025, with 36.02% growth.
Revenue
21.11B
Revenue Growth
+23.82%
P/S Ratio
2.10
Revenue / Employee
7.34M
Employees
2,875
Market Cap
44.29B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 21.11B | 4.06B | 23.82% |
Mar 31, 2024 | 17.05B | 3.62B | 26.94% |
Mar 31, 2023 | 13.43B | 731.90M | 5.76% |
Mar 31, 2022 | 12.70B | 346.97M | 2.81% |
Mar 31, 2021 | 12.35B | 1.31B | 11.91% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Mankind Pharma | 122.07B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |
Unichem Laboratories News
- 21 days ago - Unichem Labs Q4 Results: Revenue up 27.9% YoY to Rs 587.18 crore, company swings back to net profit - Business Upturn
- 4 weeks ago - Unichem Laboratories receives USFDA EIR for Pithampur facility; inspection classified as VAI - Business Upturn
- 2 months ago - Unichem Laboratories shares rise 2.35% as API plant expansion boosts production capacity - Business Upturn
- 3 months ago - Unichem Laboratories completes Phase I expansion of API plant at Pithampur with Rs 200 crore investment - Business Upturn
- 4 months ago - Unichem Laboratories Q3 results: Revenue rises 14.4% YoY to Rs 533 crore, Net profit falls 21% YoY - Business Upturn